186 related articles for article (PubMed ID: 7485014)
1. Modulatory impact of acid and pepsin on esophageal hydrophobicity in humans.
DeRosa J; Marcinkiewicz M; Sarosiek J; Edmunds M; McCallum RW
Am J Gastroenterol; 1995 Nov; 90(11):2020-4. PubMed ID: 7485014
[TBL] [Abstract][Full Text] [Related]
2. Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.
Rourk RM; Namiot Z; Edmunds MC; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Aug; 89(8):1177-84. PubMed ID: 8053431
[TBL] [Abstract][Full Text] [Related]
3. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.
Rourk RM; Namiot Z; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Feb; 89(2):237-44. PubMed ID: 8304310
[TBL] [Abstract][Full Text] [Related]
4. Impact of acid and pepsin on human esophageal prostaglandins.
Sarosiek J; Yu Z; Namiot Z; Rourk RM; Hetzel DP; McCallum RW
Am J Gastroenterol; 1994 Apr; 89(4):588-94. PubMed ID: 8147363
[TBL] [Abstract][Full Text] [Related]
5. Effect of esophageal intraluminal mechanical and chemical stressors on salivary epidermal growth factor in humans.
Li L; Yu Z; Piascik R; Hetzel DP; Rourk RM; Namiot Z; Sarosiek J; McCallum RW
Am J Gastroenterol; 1993 Oct; 88(10):1749-55. PubMed ID: 8213719
[TBL] [Abstract][Full Text] [Related]
6. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease.
Marcinkiewicz M; Han K; Zbroch T; Poplawski C; Gramley W; Goldin G; Sarosiek J
Am J Gastroenterol; 2000 Jul; 95(7):1652-60. PubMed ID: 10925964
[TBL] [Abstract][Full Text] [Related]
7. Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans.
Sarosiek J; Hetzel DP; Yu Z; Piascik R; Li L; Rourk RM; McCallum RW
Am J Gastroenterol; 1993 Jul; 88(7):1081-7. PubMed ID: 8317410
[TBL] [Abstract][Full Text] [Related]
8. Interrelationship between esophageal challenge with mechanical and chemical stimuli and salivary protective mechanisms.
Namiot Z; Rourk RM; Piascik R; Hetzel DP; Sarosiek J; McCallum RW
Am J Gastroenterol; 1994 Apr; 89(4):581-7. PubMed ID: 8147362
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of esophageal intraluminal mechanical and chemical stressors on salivary prostaglandin E2 in humans.
Namiot Z; Yu ZJ; Piascik R; Hetzel DP; McCallum RW; Sarosiek J
Am J Med Sci; 1997 Feb; 313(2):90-8. PubMed ID: 9030674
[TBL] [Abstract][Full Text] [Related]
10. Declined human esophageal mucin secretion in patients with severe reflux esophagitis.
Namiot Z; Sarosiek J; Marcinkiewicz M; Edmunds MC; McCallum RW
Dig Dis Sci; 1994 Dec; 39(12):2523-9. PubMed ID: 7995174
[TBL] [Abstract][Full Text] [Related]
11. Detrimental impact of acid and pepsin on the rate of luminal release of transforming growth factor alpha. Its potential pathogenetic role in the development of reflux esophagitis.
Marcinkiewicz M; Namiot Z; Edmunds MC; McCallum RW; Sarosiek J
J Clin Gastroenterol; 1996 Dec; 23(4):261-8. PubMed ID: 8957727
[TBL] [Abstract][Full Text] [Related]
12. Human esophageal secretion: mucosal response to luminal acid and pepsin.
Namiot Z; Sarosiek J; Rourk RM; Hetzel DP; McCallum RW
Gastroenterology; 1994 Apr; 106(4):973-81. PubMed ID: 8144002
[TBL] [Abstract][Full Text] [Related]
13. Monophasic luminal release of prostaglandin E2 in patients with reflux esophagitis under the impact of acid and acid/pepsin solutions. Its potential pathogenetic significance.
Marcinkiewicz M; Sarosiek J; Edmunds M; Scheurich J; Weiss P; McCallum RW
J Clin Gastroenterol; 1995 Dec; 21(4):268-74. PubMed ID: 8583097
[TBL] [Abstract][Full Text] [Related]
14. What is the secretory potential of submucosal mucous glands within the human gullet in health and disease?
Sarosiek J; McCallum RW
Digestion; 1995; 56 Suppl 1():15-23. PubMed ID: 7556966
[TBL] [Abstract][Full Text] [Related]
15. Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease.
Nagahara A; Miwa H; Minoo T; Hojo M; Kawabe M; Osada T; Kurosawa A; Asaoka D; Terai T; Ohkusa T; Sato N
J Clin Gastroenterol; 2006; 40(10):891-5. PubMed ID: 17063106
[TBL] [Abstract][Full Text] [Related]
16. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action.
Shafik A; El-Sibai O; Shafik AA; Mostafa R
J Gastroenterol Hepatol; 2005 Dec; 20(12):1935-9. PubMed ID: 16336456
[TBL] [Abstract][Full Text] [Related]
18. Effect of different doses of GLP-2 (Teduglutide) on acute esophageal lesion due to acid-pepsin perfusion in male rats.
Moloudi R; Nabavizadeh F; Nahrevanian H; Hassanzadeh G
Peptides; 2011 Oct; 32(10):2086-90. PubMed ID: 21930171
[TBL] [Abstract][Full Text] [Related]
19. Acid sensitization of esophageal mucosal afferents: implication for symptom perception in patients across the gastroesophageal reflux disease spectrum.
Szczesniak MM; Fuentealba SE; Cook IJ
Clin J Pain; 2013 Jan; 29(1):70-7. PubMed ID: 22330131
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E(2) mediates acid-induced heartburn in healthy volunteers.
Kondo T; Oshima T; Tomita T; Fukui H; Watari J; Okada H; Kikuchi S; Sasako M; Matsumoto T; Knowles CH; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G568-73. PubMed ID: 23370674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
